Thanks to our work, a new therapy using an old ally has been tested for an angiopathy that until now was considered incurable. A genuine game-changer for these patients.
Snorradottir AO, Gutierrez-Uzquiza A, Bragado P, et al. N-Acetylcysteine for hereditary cystatin C amyloid angiopathy: a nonrandomized clinical trial. JAMA Neurology. 2025 May 1;82(5):486-494.
